Hannes Snellman Counsel to MedCap in Its Divestment of Vitamin D
19 August 2022
Hannes Snellman acted as counsel to MedCap, who has through its subsidiary Unimedic Pharma AB, divested its rights to the product Vitamin D to Pharmaprim AB.
MedCap is a publicly listed company operating within the life sciences industry.
Hannes Snellman’s core team included Claes Kjellberg, Miklos Kovacs Kal, and Emma Andersson.